6
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Low Dose of ACE-Inhibitor Enhances Sodium Excretion in Volume Expanded Patients with Borderline Hypertension

, , , , , , & show all
Pages 105-112 | Received 31 Jul 1995, Accepted 31 Aug 1995, Published online: 08 Jul 2009

References

  • Dahl LK. Salt and hypertension. Am J Clin Nutr 1972; 25: 231–44
  • Weinberger MH. Sodium chloride and blood pressure. N Engl J Med 1987; 317: 1084–86
  • Dahl LK. Metabolic aspects of hypertension. Ann Rev Med 1963; 14: 69–98
  • Kaplan NM. New evidence on the role of sodium in hypertension. The Intersalt Study. Am J Hypertens 1990; 3: 168–9
  • Bianchi G, Ferrari P, Salvati P. A renal abnormality in the Milan hypertensive strain of rats and humans predisposed to essential hypertension. J Hypertens 1986; 4: 33–6, (Suppl 3)
  • Van Hooft IMS, Grobbee DE, Derkx FHM, De Leeuw PW, Schalekamp MADH, Hofman A. Renal hernodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991; 324: 1305–11
  • De Wardener HE. Kidney, salt intake, and Na+ + -ATPase inhibitors in hypertension. Hypertension 1991; 17: 830–6
  • Borghi C, Boschi S, Costa FV, Munarini A, Mussi A, Ainbrosioni E. Importance of plasma renin activity suppression and venous distensibility on pressor and natriuretic response to intravenous salt load in borderline hypertension. Am J Hypertens 1988; 1: 294–7
  • Borghi C, Boschi S, Costa FV, Anibrosioni E. Determinants of acute salt sensitivity in hypertension-prone man. J Hypertension 1991; 9: S318–9, (Suppl 6)
  • Luft FC, Miller JZ, Weinberger MH, Christian JC, Skrabal F. Genetic influences on the response to dietary salt reduction, acute salt loading, or salt depletion in humans. J Cardiovasc Pharmacol 1988; 12: s49–55, (Suppl 3)
  • Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profile. Am J Med 1973; 55: 261–74
  • Hollenberg NK, Williams GH. Sodium-sensitive hypertension. Implications of pathogenesis for therapy. Am J Hypertens 1989; 2: 809–15
  • Cogan MG. Angiotensin II: A powerful controller of sodium transport in the early proximal tubule. Hypertension 1990; 15: 451–8
  • Weber MA, Neutel JM, Smith DHG. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition. Am Heart J 1992; 123: 1414–20
  • Hannedouche T, Delgado A, Gnionsahe A, Lacour B, Grunfeld JP. Influence of captopril on renal hemodynamics and segmental tubular reabsorption of sodium in humans. J Cardiovasc Pharmacol 1989; 13: 84–9
  • Hollenberg NK, Meggs LG, Williams GH, Katz J, Garvic JD, Harrington DP. Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int 1981; 20: 240–5
  • Borghi C, Boschi S, Costa FV, Ambrosioni E. Atrial natriuretic factor response to acute volume expansion in borderline hypertension. Role of ACE-inhibition and changes in peripheral venous tone. Clin Exp Hypertens 1993; 15: 339–54
  • Mimran A, Ribstein J. Effects of captopril on the blood pressure and renal responses to acute saline loading in normal and essential hypertensive subjects. Clin Sci 1982; 63: 223s–5
  • Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Vaughn ED, Jr. Renin, angiotensin and aldosterone system in the pathogenesis and management of hypertensive vascular disease. Am J Med 1972; 52: 633–52
  • Dimsdale JE, Ziegler M, Mills P, Berry C. Prediction of salt sensitivity. Am J Hypertens 1990; 3: 429–35
  • Rydstedt LL, Williams GH, Hollemberg NK. Renal and endocrine response to saline infusion in essential hypertension. Hypertension 1986; 8: 217–22
  • Rabinowe SL, Redgrave JE, Shoback DM, Podolsky S, Hollemberg NK, Williams GH. Renin suppression is blunted in non modulating essential hypertension. Hypertension 1987; 10: 404–8
  • Vinci JM, Horwitz D, Zusmann RM, Pisano JJ, Catt KJ, Keiser HR. The effect of converting enzyme inhibition with SQ 20, 881 011 plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Hypertension 1979; 1: 416–26
  • Mizelle LH, Montani JP, Hester RL, Didlake RH, Hall JE. Role of pressure natriureisis in long-term control of renal electrolyte excretion. Hypertension 1993; 22: 102–10
  • Roman RJ, Cowley AW, Jr. Characterization of a new model for the study of pressure natriuresis in the rat. Am J Physiol 1985; 248: F190–8
  • Shipley RE, Study RS. Changes in renal blood How, extraction of inulin, glomerular filtration rate, tissue pressure and urine flow with acute alterations in renal perfusion pressure. Am J Physiol 1951; 167: 676–88
  • Thompson DD, Pitts RF. Effects of alterations of renal arterial pressure on sodium and water excretion. Am J Physiol 1951; 168: 490–9
  • Burnett JC. Atrial natriuretic factor secretion: physiological regulation and implications in cardiovascular disease. Curr Opin Cardiol 1987; 2: 653–9
  • Dessi-Fulgheri P. M., Otolese M, D i Noto M. Blunting of atrial natriuretic factor response to volume expansion by benazepril in hypertensive patients. J Hypertens 1989; 7: S300–1, (Suppl 6)
  • Wilkins MR, Lewis HM, West MJ, Kendall MJ, Lotes CJ. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives. J Hum Hypertens 1987; 1: 47–51
  • Tang J, Webber RJ, Chang D. Depressor and natriuretic activities of several atrial peptides. Regul Pept 1990; 9: 53–9
  • Mizelle LH, Hall JE, Hildebrandt DA. Atrial natriuretic peptide and pressure natriuresis: interaction with the renin-angiotensin system. Am J Physiol 1989; 257: R1169–74
  • Ferrari P, Weidmann P, Ferrier C, Dietler R, Hollmann R, Piso RJ. dysregulation of atrial natriuretic factor in hypertension-prone man. J Clin Endocrinol Metab 1990; 71: 944–51
  • Volpe M, Lembo G, De Luca N, Lamenza F, Tritto C, Ricciardelli B. Abnormal hormonal and renal responses to saline load in hypertensive patients with parental history of cardiovascular accidents. Circulation 1991; 84: 92–100

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.